Published in
Elsevier, EJSO - European Journal of Surgical Oncology, 8(41), p. 1097-1105
DOI: 10.1016/j.ejso.2015.04.005
Links
Tools
The role of baseline inflammatory-based scores and serum tumor markers to risk stratify pseudomyxoma peritonei patients treated with cytoreduction (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)
Journal article published in 2015 by
S. Kusamura,
D. Baratti 
,
I. Hutanu,
C. Gavazzi,
D. Morelli,
D. R. Iusco,
A. Grassi,
S. Bonomi,
S. Virzì,
E. Haeusler,
M. Deraco
,
I. Hutanu,
C. Gavazzi,
D. Morelli,
D. R. Iusco,
A. Grassi,
S. Bonomi,
S. Virzì,
E. Haeusler,
M. Deraco
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 